Dupixent ® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)
Source link
June 20, 2025
- European Leaders To Hold Talks With Iran As Conflict Continues
- DNC chair Ken Martin faces leadership challenges amid Democratic infighting
- New research says using AI reduces brain activity – but does that mean it’s making us dumber?
- FC Barcelona Set To Receive $46 Million Cash Injection By End Of Month
